Walaa Hamada Abd-Allah

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Diffuse Large B Cell Lymphoma

Temporal Lobe Epilepsy

Acinetobacter Baumannii

Top Venues

Drug development research

Journal of medicinal chemistry

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem (2024)
Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem 19 (10) (2024)
Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem 19 (10) (2024)
Walaa Hamada Abd-Allah, Mostafa Abd El-Mohsen Anwar, Eman R Mohammed, Samir M El Moghazy
Anticonvulsant Classes and Possible Mechanism of Actions. ACS chemical neuroscience (2023)
Ahmed H Tantawy, Mohammed Farrag El-Behairy, Walaa Hamada Abd-Allah, Hong Jiang, Man-Qun Wang, Adel A Marzouk
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Fluorinated Candidates as PI3K Inhibitors: Targeting Fluorophilic Binding Sites. Journal of medicinal chemistry 64 (23) (2021)
Walaa Hamada Abd-Allah, Asmaa Salman, Samah Sabry Saad
Anticancer activity of newly synthesized 1,1-disubstituted cyclohexane-1-carboxamides: in vitro caspases mediated apoptosis activators in human cancer cell lines and their molecular modeling. Drug development research 80 (7) (2019)